Lendlease Global Commercial REIT – Weighed down by lower rents August 13, 2021 884

PSR Recommendation: NEUTRAL Status: Downgraded
Target Price: 0.870
  • FY21 NPI missed, but DPU met expectations. Revenue and NPI at 92.4%/91.6% of our FY21e estimates, due to lower rental income during Phase 2HA.
  • Lacklustre tenant sales and mall visitors may continue as safe-distancing measures and border closures remain in place. Rents weighed down by negative reversions.
  • Downgrade to NEUTRAL from ACCUMULATE. Our DDM target price, however, climbs to S$0.87 from S$0.82 (COE 8%) as we roll over our estimates and assume that LREIT will acquire an additional 5% stake in Jem by the end of FY22. Recent share-price appreciation has priced in most positives, in our view.

 

The Positives

+ FY21 NPI missed, but DPU met expectations. Revenue and NPI were lower than expected at 92.4%/91.6% of FY21e estimates, attributable to a decline in rental income during Phase 2HA. That said, annualised FY21 gross revenue and NPI were still 5.6%/5.4% higher YoY. This was due to lesser rental waivers for 313@somerset. Expenses were higher in FY21 mainly because of provisions for doubtful debts of S$2.3mn. Distributable income and DPU were in line, at 99%/98.7% of our FY21e estimates. They were aided by higher net FX gains of S$5.4mn in 2H21.

 

The Negative

– Lower portfolio valuation. Both 313 and Sky Complex’s fair values fell 2.5%, attributable to higher discount rates of 6.15-6.75% vs. 6.00-6.75% in FY20. The valuers also project longer rent-free periods of 1-2 years and lower renewal rates. This was partially offset by a slightly higher 10-year average market rental growth rate of 2.85%, up 0.05% from the previous year. Overall, portfolio valuation dipped 1.2%, held up by the Grange Road carpark redevelopment. LREIT was appointed project manager for this site on 18 February 2021.

Outlook

2H21 tenant sales and mall visitors grew 33.7% and 6.2% YoY respectively, from their low bases in 2H20 during Singapore’s circuit breaker. 313’s occupancy inched up QoQ from 98.6% to 99.2%, after LREIT secured three new tenants in 4Q21. To replace Forever 21’s lease which expired in FY21, LREIT brought in Marks and Spencer on a short-term lease of less than a year. M&S is looking to extend its lease while LREIT has a few other prospects interested in the space.

 

Tenant sales and mall visitors may remain muted even as Singapore resumes economic and community activities in a calibrated way. Demand for retail space is likely to remain soft with continued safe distancing and border closures. Although rental reversions are improving QoQ, they remain negative, in the double digits. Weak demand may continue to weigh on 313’s rentals. Office vacancy in Milan was stable at 9.6% in 1Q21. With a long WALE of 10.9 years, income contributions from Sky Complex are expected to be resilient.

 

Grange Road’s carpark redevelopment is expected to commence at end-2021. Development costs may increase 20-30% from the S$10mn guided previously due to supply and manpower constraints. In mitigation, LREIT has managed to unlock additional NLA which is not part of its initial calculations. Returns on investment are still expected to be in the mid-teens.

 

On 7 June 2021, LREIT completed its acquisition of a 13.25% stake in Jem via its acquisition of a 53% interest in Lendlease Jem Partners Fund Limited. LREIT is in the midst of completing its acquisition of the 3.75-14.8% stake in Jem, via an acquisition of a 5-19.8% stake in Lendlease Asian Retail Investment Fund 3 (ARIF3). Both investments will cost S$204.1-337.3mn. Should LREIT acquire 19.8% of ARIF3, it will own up to 31.8% in Jem. The acquisitions will be financed by internal cash, debt facilities and proceeds from its recent issuance of perpetual securities. Based on proforma 1H21 numbers, they are expected to be yield-accretive, at 3%.

 

If LREIT acquires the 19.8% stake in ARIF3, its portfolio will expand by 18% to S$1.8bn. Apart from increased exposure to the suburban retail segment which has been resilient during the COVID-19 pandemic, 313 – LREIT’s largest asset – would represent no more than 56% of its enlarged portfolio, reducing its concentration risks. Furthermore, LREIT could potentially increase its strategic stake in Jem further, to support its near-term growth plans.

 

Downgrade to NEUTRAL from ACCUMULATE; DDM target price climbs to S$0.87 from S$0.82. We lower FY22e revenue and NPI estimates by 6% and 4% respectively to reflect slower rent growth. On the other hand, our TP rises as we roll over to FY22. We assume that LREIT will complete its acquisition to own 31.8% interest in Jem and acquire an additional 5% stake by the end of FY22. This will be funded via internal cash and debt. Recent share-price rally of 16% has priced in its positives, in our view. Downgrade from ACCUMULATE to NEUTRAL.

 
 

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!